Echo Therapeutics (ECTE) Misses Q2 EPS by 8c
Tweet
Share
E-mailGet Alerts ECTE Hot Sheet
Price: $0.00 --0%
Financial Fact:
Total operating expenses: 1.81M
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Total operating expenses: 1.81M
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Echo Therapeutics (NASDAQ: ECTE) reported Q2 EPS of ($0.31), $0.08 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $19.1 million, versus $22.56 million reported last year.
For earnings history and earnings-related data on Echo Therapeutics (ECTE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- China semiconductor equipment imports grow 9% in July, Barclays comments
- JPMorgan Downgrades Rockwool (ROCKB:DC) (RKWBF) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
